CVS HealthvsMerck & Company

CVS and MRK stock compared: price, dividend, valuation and results, from SEC filings.

CVS

CVS Health Corporation

$89.35

Value $114B

-0.49%
CVS's page

MRK

Merck & Company, Inc.

$147.76

Value $365B

+0.55%
MRK's page

CVS Health (CVS) has a market value of $114B and Merck & Company (MRK) $365B. Over the last year, with dividends, CVS moved +14.7% and MRK +66.3%. The P/E is 10.3 for CVS and 148.9 for MRK. Dividend yield: CVS 2.98%, MRK 2.30%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CVS$114B

    MRK$365B

    MRK is 3.2 times CVS

  • Revenue, 12 months

    CVS$421B

    MRK$67.4B

    CVS is 6.2 times MRK

  • Net income, 12 months

    CVS$11.0B

    MRK$2.5B

    CVS is 4.5 times MRK

  • Operating margin

    CVS3.6%

    MRK–

  • ROIC

    CVS9.8%

    MRK3.9%

    5.9 points apart

  • P/E

    CVS10.3

    MRK148.9

    MRK is 14 times CVS

  • Dividend yield

    CVS3.0%

    MRK2.3%

    0.7 points apart

  • 5-year return

    CVS+12.2%

    MRK+104.9%

    92.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CVS+12.2%

MRK+104.9%

5010015020020222023202420252026
Returns by period
PeriodCVSWith dividendsMRKWith dividends
1 year since November 12, 2025+14.7%Price +11.3%+66.3%Price +61.6%
3 years since November 13, 2023+47.4%+13.8% a yearPrice +31.8%+58.0%+16.5% a yearPrice +44.2%
5 years since November 12, 2021+12.2%+2.3% a yearPrice -5.0%+104.9%+15.4% a yearPrice +75.9%
10 years since November 15, 2016+62.4%+5.0% a yearPrice +19.1%+230.1%+12.7% a yearPrice +143.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CVSCVS HealthMRKMerck & Company

Valuation

CVSMRK
Valuation
Price$89.35$147.76
Market value$114B$365B
Enterprise value (EV)$159B$409B
P/E10.3148.9
P/E, 5-year median17.114.8
P/B1.48.1
EV/EBIT10.686.0
Free cash flow yield13.7%4.0%

Results and growth

CVSMRK
Results and growth
Revenue, 12 months$421B$67.4B
Net income, 12 months$11.0B$2.5B
Free cash flow, 12 months$15.6B$14.7B
Earnings per share, 12 months$8.61$0.98
Revenue growth, year on year7.9%1.3%
Revenue growth a year, past+8.4%over 5 years+9.4%over 5 years
EPS growth a year, past-23.9%over 5 years+21.2%over 5 years

Margins and returns on capital

CVSMRK
Margins and returns on capital
Gross margin44.2%71.8%
Operating margin3.6%–
Net margin2.6%3.6%
ROIC9.8%3.9%
ROE14.3%5.2%

Balance sheet

CVSMRK
Balance sheet
Cash$14.9B$9.7B
Total debt$75.3B$53.8B
Net debt / EBITDA2.35.7
Interest cover4.9×2.4×

Dividends and buybacks

CVSMRK
Dividends and buybacks
Dividend yield3.0%2.3%
Dividend per share, 12 months$2.66$3.40
Dividend growth a year, past+5.9%over 5 years+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield3.0%3.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CVS or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, CVS Health or Merck & Company?

By market value, Merck & Company ($365B) is about 3.2 times CVS Health ($114B), at today's prices.

How did CVS and MRK stock do over the last 10 years?

Since November 15, 2016, CVS's price moved +19.1% and MRK's +143.3%. With dividends: CVS +62.4% (+5.0% a year), MRK +230.1% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, CVS or MRK?

The dividend yield at today's price is 2.98% for CVS Health and 2.30% for Merck & Company. Over the last twelve months they paid $2.66 and $3.40 per share.

What is the P/E of CVS and MRK?

At today's price, the P/E is 10.3 for CVS and 148.9 for MRK. The median of the last five years was 17.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, CVS Health or Merck & Company?

Over the last twelve months, the net margin was 2.6% for CVS Health and 3.6% for Merck & Company, and the operating margin 3.6% and –. Revenue was $421B and $67.4B.

Which is the better investment, CVS Health or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.